DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Statistics

Total Valuation

DOD Biotech PCL has a market cap or net worth of THB 684.63 million. The enterprise value is 471.84 million.

Market Cap	684.63M
Enterprise Value	471.84M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

DOD Biotech PCL has 450.41 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	450.41M
Shares Outstanding	450.41M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	32.20%
Owned by Institutions (%)	19.52%
Float	261.26M

Valuation Ratios

The trailing PE ratio is 19.77.

PE Ratio	19.77
Forward PE	n/a
PS Ratio	1.08
PB Ratio	0.73
P/TBV Ratio	0.76
P/FCF Ratio	11.08
P/OCF Ratio	6.69
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.64, with an EV/FCF ratio of 7.63.

EV / Earnings	9.25
EV / Sales	0.75
EV / EBITDA	5.64
EV / EBIT	11.10
EV / FCF	7.63

Financial Position

The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.05.

Current Ratio	4.38
Quick Ratio	3.11
Debt / Equity	0.05
Debt / EBITDA	0.54
Debt / FCF	0.73
Interest Coverage	16.38

Financial Efficiency

Return on equity (ROE) is 3.28% and return on invested capital (ROIC) is 4.25%.

Return on Equity (ROE)	3.28%
Return on Assets (ROA)	2.27%
Return on Invested Capital (ROIC)	4.25%
Return on Capital Employed (ROCE)	4.23%
Weighted Average Cost of Capital (WACC)	8.36%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.54
Inventory Turnover	3.37

Taxes

In the past 12 months, DOD Biotech PCL has paid 11.09 million in taxes.

Income Tax	11.09M
Effective Tax Rate	26.91%

Stock Price Statistics

The stock price has increased by +14.29% in the last 52 weeks. The beta is 0.80, so DOD Biotech PCL's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+14.29%
50-Day Moving Average	1.58
200-Day Moving Average	1.72
Relative Strength Index (RSI)	44.41
Average Volume (20 Days)	242,747

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DOD Biotech PCL had revenue of THB 632.68 million and earned 50.99 million in profits. Earnings per share was 0.11.

Revenue	632.68M
Gross Profit	227.40M
Operating Income	42.49M
Pretax Income	41.20M
Net Income	50.99M
EBITDA	81.04M
EBIT	42.49M
Earnings Per Share (EPS)	0.11

Balance Sheet

The company has 253.66 million in cash and 45.17 million in debt, with a net cash position of 208.49 million or 0.46 per share.

Cash & Cash Equivalents	253.66M
Total Debt	45.17M
Net Cash	208.49M
Net Cash Per Share	0.46
Equity (Book Value)	941.11M
Book Value Per Share	2.10
Working Capital	355.10M

Cash Flow

In the last 12 months, operating cash flow was 102.36 million and capital expenditures -40.55 million, giving a free cash flow of 61.81 million.

Operating Cash Flow	102.36M
Capital Expenditures	-40.55M
Free Cash Flow	61.81M
FCF Per Share	0.14

Margins

Gross margin is 35.94%, with operating and profit margins of 6.72% and 8.06%.

Gross Margin	35.94%
Operating Margin	6.72%
Pretax Margin	6.51%
Profit Margin	8.06%
EBITDA Margin	12.81%
EBIT Margin	6.72%
FCF Margin	9.77%

Dividends & Yields

DOD Biotech PCL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	0.01%
Earnings Yield	7.45%
FCF Yield	9.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DOD Biotech PCL has an Altman Z-Score of 4.01 and a Piotroski F-Score of 6.

Altman Z-Score	4.01
Piotroski F-Score	6